PUBLISHER: Grand View Research | PRODUCT CODE: 1869749
PUBLISHER: Grand View Research | PRODUCT CODE: 1869749
The global urinary catheters market size was estimated at USD 6.17 billion in 2024 and is projected to reach USD 10.93 billion by 2033, growing at a CAGR of 6.62% from 2025 to 2033. The growth of the market is attributed to the rising prevalence of urological disorders such as urinary incontinence, benign prostatic hyperplasia (BPH), and spinal cord injuries, which necessitate long-term catheterization.
The growing aging population and increasing number of surgical procedures and hospitalizations further fuel product demand. In addition, the expanding adoption of home healthcare and the rising preference for minimally invasive and non-invasive urinary management solutions, such as external and intermittent catheters, are accelerating market growth. Technological advancements, including antimicrobial coatings and silicone-based materials that enhance patient comfort and reduce infection risk, along with greater awareness among patients and caregivers about urinary management options, are expected further to support the market's expansion over the forecast period.
The increasing burden of urologic disorders, such as urinary incontinence (UI), benign prostatic hyperplasia (BPH), and spinal cord injury (SCI), is emerging as a significant contributor to the rising demand for urinary catheters. According to data published by the National Center for Biotechnology Information (NCBI) in August 2024, an estimated 13 million individuals in the U.S. are directly affected by urinary incontinence. Similarly, data from Continence Health Australia in March 2024 indicates that urinary incontinence affects up to 10% of Australian men and as many as 38% of Australian women. This substantial and growing burden of urinary incontinence is fueling increased demand for urinary catheters, particularly external urinary catheters used in the management of the condition.
Furthermore, the rising prevalence of benign prostatic hyperplasia (BPH) is projected to significantly boost the demand for urinary catheters in the coming years. Urinary catheters are vital in managing BPH by providing immediate relief from urinary retention and improving patients' overall quality of life. For individuals affected by BPH, catheters facilitate urine drainage by bypassing the obstruction caused by an enlarged prostate. Given their critical role in symptom management and patient care, the increasing incidence of BPH is expected to drive sustained growth in the urinary catheters market.
The increasing demand for external catheters designed for home care settings is anticipated to be a major growth driver for the urinary catheters market over the forecast period. With rising awareness of non-invasive urinary management solutions, healthcare providers and caregivers are increasingly favoring safer and more comfortable alternatives to traditional indwelling catheters. Industry feedback has been highly positive, underscoring the strong market potential for these products. A key instance is BD's PureWick System, which has garnered consistent support from patients, caregivers, and healthcare professionals. As of August 2024, more than 50 million PureWick Female External Catheters and over 5 million PureWick Male External Catheters had been utilized across acute and home care environments, reflecting the growing adoption of external catheter solutions.
Global Urinary Catheters Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global urinary catheters market report on the basis of product, application, type, gender, end use, and region: